Skip to content

SURGUARD3 SG3+03L2138Recalls & reported problems

Terumo (Philippines) Corporation · SURGUARD3 Hypodermic Syringe with Safety Needle · Class 2

All models of SURGUARD3 (19)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 14806017509283), received between Aug 10, 2020 and Aug 10, 2020 — classified as 1 malfunction.

The most frequently reported specific device problem is “Activation Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Activation Failure1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 10, 2020Activation Failure; Activation Failure

    THE USER FACILITY REPORTED THAT THE MALE NURSE THAT THE PROTECTION MECHANISM OF THE CANNULA WAS USED AFTER THE INJECTION WAS ADMINISTERED BUT DID NOT APPEAR TO HAVE LOCKED. SYRINGE IS NOT AVAILABLE. ADMINISTRATION WAS PRIOR TO EXPIRY DATE. THE PATIENT WAS NOT HARMED. ADDITIONAL INFORMATION WAS RECEIVED ON 29JULY2020: THE PROTECTION MECHANISM OF THE CANNULA DID NOT APPEAR TO HAVE LOCKED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10385699 ↗

Other SYRINGE, ANTISTICK devices

All SYRINGE, ANTISTICK devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page